Cellectis SA (CLLS)
3.10
-0.02
(-0.64%)
USD |
NASDAQ |
Sep 11, 16:00
3.09
-0.01
(-0.32%)
After-Hours: 20:00
Cellectis Enterprise Value : 249.60M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 249.60M |
| September 10, 2026 | 251.61M |
| September 09, 2026 | 252.62M |
| September 08, 2026 | 255.64M |
| September 04, 2026 | 263.70M |
| September 03, 2026 | 271.75M |
| September 02, 2026 | 264.70M |
| September 01, 2026 | 269.74M |
| August 31, 2026 | 274.77M |
| August 28, 2026 | 279.81M |
| August 27, 2026 | 295.42M |
| August 26, 2026 | 281.82M |
| August 25, 2026 | 281.82M |
| August 24, 2026 | 258.66M |
| August 21, 2026 | 280.31M |
| August 20, 2026 | 286.86M |
| August 19, 2026 | 256.65M |
| August 18, 2026 | 243.56M |
| August 17, 2026 | 250.61M |
| August 14, 2026 | 244.56M |
| August 13, 2026 | 257.66M |
| August 12, 2026 | 233.49M |
| August 11, 2026 | 228.45M |
| August 10, 2026 | 215.36M |
| August 07, 2026 | 222.91M |
| Date | Value |
|---|---|
| August 06, 2026 | 208.31M |
| August 05, 2026 | 218.38M |
| August 04, 2026 | 216.37M |
| August 03, 2026 | 214.36M |
| July 31, 2026 | 214.36M |
| July 30, 2026 | 224.42M |
| July 29, 2026 | 225.43M |
| July 28, 2026 | 223.42M |
| July 27, 2026 | 228.45M |
| July 24, 2026 | 223.42M |
| July 23, 2026 | 216.37M |
| July 22, 2026 | 219.39M |
| July 21, 2026 | 208.31M |
| July 20, 2026 | 199.25M |
| July 17, 2026 | 202.27M |
| July 16, 2026 | 206.30M |
| July 15, 2026 | 220.40M |
| July 14, 2026 | 226.94M |
| July 13, 2026 | 229.46M |
| July 10, 2026 | 238.52M |
| July 09, 2026 | 256.95M |
| July 08, 2026 | 248.59M |
| July 07, 2026 | 261.68M |
| July 06, 2026 | 268.73M |
| July 02, 2026 | 269.74M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DBV Technologies SA | 488.42M |
| Akari Therapeutics Plc | 12.72M |
| EDAP TMS SA | 173.81M |
| Autolus Therapeutics Plc | 665.07M |
| Evaxion AS | 19.21M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.79M |
| Revenue (Quarterly) | 5.222M |
| Total Expenses (Quarterly) | 27.01M |
| EPS Diluted (Quarterly) | -0.2165 |
| Gross Profit Margin (Quarterly) | 15.62% |
| Profit Margin (Quarterly) | -417.3% |
| Earnings Yield | -20.97% |
| Normalized Earnings Yield | -19.31 |